CNS Pharmaceuticals, Inc.
Pharmaceutical Preparations · Houston, TX, United States
- PrincipalsChristopher DownsChief Financial OfficerEric FaulknerChief Technology OfficerJohn M ClimacoChief Executive Officerand 7 more
- CompanyCNS Pharmaceuticals, Inc.Houston, TX, United States
- Phone line+1 (800) 946-9185General business
CNS Pharmaceuticals, Inc. is an SEC-registered Nasdaq-listed company (ticker CNSP) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 10
Chair & board
Amy MaheryDirector (Board)
Bettina M. CockroftDirector (Board)
Faith L. CharlesDirector (Board)
Jeffry R. KeyesDirector (Board)
Technology & engineering
Eric FaulknerChief Technology Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Eric Faulkner — Chief Technology Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Rami Levin — CEO and President
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Christopher Downs — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗John M Climaco — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Cannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityQuantum Cyber N.V.Pharmaceutical Preparations · Mainz1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capability